GO:0015822 ornithine transport: Mitochondrial Urea Cycle and Cellular Transport, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015822 (ornithine transport) describes the directed movement of ornithine, 2,5-diaminopentanoic acid, into, out of, or within a cell, or between cells, by means of a transporter or pore.
• Ornithine transport is essential for the urea cycle, polyamine biosynthesis, and cellular nitrogen handling, and it occurs across mitochondrial, plasma, and peroxisomal membranes [3,5].
• Key transporters include the mitochondrial ornithine/citrulline carrier (ORC/SLC25A15), cationic amino acid transporter 1 (CAT1/SLC7A1), and the peroxisomal SLC45A4 putrescine transporter [3,4,5,7,8].
• Defective ornithine transport is linked to hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, retinal cytotoxicity, and cystinuria-related transport defects [2,4,7].
• Single-cell metabolic modeling has revealed that ornithine transport and metabolism regulate Th17 cell autoimmunity, linking transport to immune cell function.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of ornithine transporters in disease and metabolism [1,4,7].
Description
Ornithine transport (GO:0015822) is the directed movement of ornithine, 2,5-diaminopentanoic acid, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Ornithine is a non-proteinogenic amino acid central to the urea cycle, polyamine synthesis, and nitrogen disposal, and its movement across membranes is required for these pathways to function [3,5]. The term encompasses transport across the mitochondrial inner membrane, the plasma membrane, and peroxisomal membranes, mediated by distinct carrier proteins [3,4,5,7,8]. Researchers study ornithine transport because it connects amino acid metabolism to organelle function, cellular energetics, and disease. The mitochondrial ornithine/citrulline carrier (ORC) exchanges ornithine for citrulline and also catalyzes ornithine+/H+ exchange, a mechanism critical for urea cycle flux [3,5]. At the plasma membrane, cationic amino acid transporter 1 (CAT1/SLC7A1) mediates ornithine uptake in retinal pigment epithelial cells and contributes to ornithine cytotoxicity [4,7]. More recently, SLC45A4 was identified as a peroxisomal putrescine transporter that promotes GABA de novo synthesis, expanding the transport landscape for ornithine-related metabolites. Because ornithine transport is implicated in hyperammonemia, retinal degeneration, cystinuria, and autoimmune T cell regulation, it is a compelling target for functional genomics and therapeutic development [1,2,4,7]. This article synthesizes the authoritative GO definition with verified PubMed literature to provide a research-grade overview of ornithine transport, its genes, mechanisms, disease links, and experimental models.
ornithine transport At A Glance
| GO ID | GO:0015822 |
|---|---|
| GO term | ornithine transport |
| Ontology | biological_process |
| Synonym | L-ornithine transport |
| Definition | The directed movement of ornithine, 2,5-diaminopentanoic acid, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| Major function | Transports ornithine across mitochondrial, plasma, and peroxisomal membranes to support urea cycle, polyamine synthesis, and nitrogen metabolism. |
| Key transporters | ORC/SLC25A15, CAT1/SLC7A1, SLC45A4 |
| Related pathways | Urea cycle, polyamine biosynthesis, GABA synthesis, amino acid transport |
| Disease relevance | HHH syndrome, retinal cytotoxicity, cystinuria, autoimmunity |
What Is GO:0015822?
GO:0015822 (ornithine transport) is defined as the directed movement of ornithine, 2,5-diaminopentanoic acid, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. The synonym L-ornithine transport is also used. This biological process includes mitochondrial ornithine/citrulline exchange, plasma membrane cationic amino acid transport, and peroxisomal transport of ornithine-related metabolites [3,4,5,7,8].
Why Is ornithine transport Important in Cell Biology?
Ornithine transport is important because it controls the availability of ornithine for the urea cycle, polyamine biosynthesis, and other metabolic pathways, and its dysfunction is linked to severe human disorders including hyperammonemia, retinal degeneration, and cystinuria [2,3,4,5,7]. Understanding the transporters and regulatory mechanisms of ornithine transport provides insight into cellular nitrogen handling, organelle communication, and potential therapeutic targets [1,3,8].
• Enables urea cycle flux by exchanging ornithine for citrulline across the mitochondrial inner membrane [3,5].
• Supports polyamine synthesis, which is required for cell proliferation and differentiation.
• Mediates ornithine uptake in retinal pigment epithelial cells, where excess ornithine causes cytotoxicity [4,7].
• Is implicated in cystinuria, a disorder of amino acid transport in the kidney.
• Links to autoimmune regulation, as single-cell metabolic modeling of Th17 cells reveals ornithine transport as a regulator of autoimmunity.
• Expands to peroxisomal transport of ornithine-related metabolites via SLC45A4, influencing GABA synthesis.
• Provides targets for CRISPR-based functional studies of amino acid transporters [1,4,7].
• Serves as a model for understanding mitochondrial carrier mechanisms and ion exchange [3,5].
• Has potential for therapeutic modulation in hyperammonemic disorders and retinal diseases [3,4,7].
• Contributes to systems-level metabolic models of immune and metabolic tissues.
What Happens During ornithine transport?
Mitochondrial ornithine/citrulline exchange
In simple terms: Ornithine is swapped for citrulline across the mitochondrial membrane to keep the urea cycle running.
The mitochondrial ornithine/citrulline carrier (ORC) catalyzes the exchange of ornithine for citrulline across the inner mitochondrial membrane, a step essential for urea cycle function. Purified and reconstituted ORC from rat liver mitochondria also catalyzes a second transport mode: ornithine+/H+ exchange, indicating that the carrier can operate in multiple modes depending on conditions. This exchange is critical for nitrogen disposal and ammonia detoxification [3,5].
Plasma membrane ornithine uptake
In simple terms: Ornithine enters cells through a transporter called CAT1 on the cell surface.
Cationic amino acid transporter 1 (CAT1/SLC7A1) mediates the transport of L-ornithine across the plasma membrane in retinal pigment epithelial cells and contributes to the blood-retinal barrier transport of ornithine. This uptake is involved in ornithine cytotoxicity in retinal pigment epithelial cells, highlighting the importance of regulated plasma membrane transport.
Peroxisomal transport of ornithine-related metabolites
In simple terms: A peroxisomal transporter moves putrescine, a molecule made from ornithine, into peroxisomes to help make GABA.
SLC45A4 encodes a peroxisomal putrescine transporter that promotes GABA de novo synthesis. Although putrescine is derived from ornithine via decarboxylation, this transport step links ornithine metabolism to peroxisomal function and neurotransmitter synthesis.
Bacterial ornithine transport and exchange
In simple terms: Bacteria also transport ornithine using specific exchange systems.
In Streptococcus lactis, ornithine transport and exchange have been characterized, demonstrating that ornithine transport is conserved across prokaryotes and eukaryotes. This bacterial system provides a model for studying transport mechanisms and energy coupling.
Key Genes Involved in GO:0015822 ornithine transport
The following genes and proteins are experimentally implicated in ornithine transport or related transport processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A15 (ORC) | Mitochondrial ornithine/citrulline carrier; exchanges ornithine for citrulline and catalyzes ornithine+/H+ exchange | Urea cycle disorders, HHH syndrome, mitochondrial transport studies [3,5] |
| SLC7A1 (CAT1) | Plasma membrane cationic amino acid transporter; mediates L-ornithine uptake | Retinal pigment epithelial cell cytotoxicity, blood-retinal barrier transport [4,7] |
| SLC45A4 | Peroxisomal putrescine transporter; promotes GABA de novo synthesis | Peroxisomal transport, GABA synthesis, metabolic studies |
| SLC3A2 | Heavy chain partner for cationic amino acid transporters | Amino acid transport complex assembly |
| SLC7A2 (CAT2) | Cationic amino acid transporter; may transport ornithine | Amino acid transport in immune and metabolic cells |
| SLC7A3 (CAT3) | Cationic amino acid transporter; may transport ornithine | Neuronal and testicular amino acid transport |
| SLC7A4 (CAT4) | Cationic amino acid transporter-like protein | Ornithine transport in specific tissues |
| OTC | Ornithine transcarbamylase; uses ornithine in urea cycle | Urea cycle disorders, ornithine availability |
| ASS1 | Argininosuccinate synthase; consumes citrulline and aspartate | Urea cycle flux, citrulline/ornithine balance |
| ASL | Argininosuccinate lyase; produces arginine and fumarate | Urea cycle, arginine metabolism |
| ARG1 | Arginase 1; produces ornithine from arginine | Ornithine supply for urea cycle and polyamines |
| ODC1 | Ornithine decarboxylase; converts ornithine to putrescine | Polyamine synthesis, cell proliferation |
| AZIN1 | Antizyme inhibitor 1; regulates ODC | Polyamine metabolism, ornithine utilization |
| SAT1 | Spermidine/spermine N1-acetyltransferase; polyamine catabolism | Polyamine homeostasis |
| SMOX | Spermine oxidase; produces putrescine | Polyamine catabolism, peroxisomal transport |
| MAOB | Monoamine oxidase B; involved in GABA synthesis | GABA synthesis, peroxisomal function |
| ABAT | 4-aminobutyrate aminotransferase; GABA catabolism | GABA metabolism |
| GAD1 | Glutamate decarboxylase 1; GABA synthesis | GABA synthesis, neuronal function |
How Is ornithine transport Regulated?
Ornithine transport is regulated at multiple levels. The mitochondrial ornithine/citrulline carrier (ORC) activity can be modulated by substrate availability and ion gradients, as it catalyzes both ornithine/citrulline exchange and ornithine+/H+ exchange. Plasma membrane transport via CAT1 is influenced by extracellular amino acid concentrations and cellular demand [4,7]. In immune cells, single-cell metabolic modeling has identified ornithine transport as a regulatory node in Th17 cell autoimmunity, suggesting that transport activity is coupled to metabolic state and inflammatory signaling. Additionally, peroxisomal putrescine transport by SLC45A4 affects GABA synthesis, which may be regulated by metabolic needs.
ornithine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A15 | HHH syndrome, hyperammonemia | Knockout mice, patient-derived iPSCs, point-mutation knock-in [3,5] |
| SLC7A1 | Retinal cytotoxicity, blood-retinal barrier dysfunction | Retinal pigment epithelial cell knockout, overexpression [4,7] |
| SLC45A4 | Peroxisomal transport defects, GABA dysregulation | Knockout cells, tagged knock-in for localization |
| SLC7A2 | Autoimmunity, metabolic disorders | Th17 cell knockout, metabolic modeling |
| OTC | Urea cycle disorders | Knockout hepatocytes, point-mutation models |
Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome
Mutations in the mitochondrial ornithine/citrulline carrier (ORC/SLC25A15) cause HHH syndrome, characterized by hyperornithinemia, hyperammonemia, and homocitrullinuria due to defective mitochondrial ornithine transport [3,5]. This disorder highlights the critical role of ornithine transport in ammonia detoxification and urea cycle function [3,5].
Retinal cytotoxicity and blood-retinal barrier transport
CAT1-mediated ornithine transport is involved in ornithine cytotoxicity in retinal pigment epithelial cells, and CAT1 impacts blood-retinal barrier transport of L-ornithine [4,7]. Dysregulation of this transport can lead to retinal damage, linking ornithine transport to retinal degenerative diseases [4,7].
Cystinuria
Cystinuria is a disorder of amino acid transport in the kidney, and early studies described defects in cystine and ornithine transport, indicating that ornithine transport pathways are relevant to renal aminoacidurias.
Autoimmunity and Th17 cells
Metabolic modeling of single Th17 cells revealed regulators of autoimmunity, including ornithine transport, suggesting that targeting ornithine transport may modulate autoimmune responses.
From ornithine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC25A15 loss impair mitochondrial ornithine transport? | SLC25A15 knockout cell lines (e.g., HEK293, HepG2) [3,5] |
| Does CAT1 mediate ornithine uptake in retinal cells? | SLC7A1 knockout and overexpression in retinal pigment epithelial cells [4,7] |
| What is the subcellular localization of SLC45A4? | Tagged knock-in of SLC45A4 with fluorescent tag |
| Does a point mutation in SLC25A15 affect transport activity? | Point-mutation knock-in via CRISPR in cell models |
| Can ornithine transport be targeted to modulate Th17 autoimmunity? | Th17 cell knockout of transport genes, metabolic assays |
| Is ornithine transport required for polyamine synthesis? | ODC1 knockout and ornithine transport inhibition |
How to Study the ornithine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate and kinetics | Characterize SLC25A15, CAT1, SLC45A4 activity [4,5,6] |
| Reconstituted proteoliposome assay | Purified transporter function | Determine exchange modes of ORC |
| Single-cell metabolic modeling | Metabolic fluxes and regulators | Identify ornithine transport regulators in Th17 cells |
| CRISPR knockout screening | Gene essentiality for transport | Discover novel ornithine transport genes [1,4] |
| Fluorescent tagging and imaging | Subcellular localization | Determine peroxisomal localization of SLC45A4 |
| Stable isotope tracing | Metabolic pathway flux | Quantify ornithine utilization in urea cycle [1,3] |
| RNA-seq | Gene expression changes | Assess transporter expression under conditions |
| Proteomics | Protein abundance and interactions | Identify transport complexes |
Transport assays
Radiolabeled ornithine uptake assays in cells or reconstituted proteoliposomes measure transport activity directly [4,5,6]. These assays can distinguish between exchange and uniport modes and are used to characterize transporter kinetics [5,6].
Metabolic modeling and flux analysis
Single-cell metabolic modeling integrates transcriptomic and metabolomic data to infer transport fluxes and identify regulators, as demonstrated in Th17 cells. Stable isotope tracing can quantify ornithine flux through urea cycle and polyamine pathways [1,3].
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for ornithine transport and sensitivity, enabling discovery of novel transporters and regulators [1,4,7].
Imaging and subcellular localization
Fluorescent tagging of transporters (e.g., SLC45A4) and live-cell imaging reveal organelle-specific localization and trafficking. Immunofluorescence can confirm mitochondrial or plasma membrane localization [4,8].
How CRISPR Can Be Used to Study GO:0015822 ornithine transport
Knockout
CRISPR knockout of SLC25A15, SLC7A1, or SLC45A4 can abolish ornithine transport, enabling loss-of-function studies in cell lines and primary cells [3,4,7,8]. Knockout models are used to assess the impact on urea cycle flux, polyamine synthesis, and retinal cell viability [3,4,7].
Point Mutation
Point mutations identified in HHH syndrome or other disorders can be introduced into SLC25A15 via CRISPR base editing or homology-directed repair to study transport defects [3,5]. Such models help distinguish pathogenic variants from benign polymorphisms.
Knock-in
Knock-in of tagged transporters (e.g., GFP-SLC45A4) allows real-time tracking of localization and dynamics. Knock-in of disease-associated mutations provides isogenic models for drug testing [3,5].
Overexpression
Overexpression of CAT1 or SLC25A15 via CRISPR activation or lentiviral delivery can enhance ornithine transport, useful for studying cytotoxicity and metabolic reprogramming [4,7]. Overexpression models help identify saturating effects and downstream consequences [4,7].
How EDITGENE Supports ornithine transport Research
Researchers studying ornithine transport-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for functional validation.
Contact EDITGENE today to design your custom CRISPR model for ornithine transport research.
Frequently Asked Questions About ornithine transport
What is ornithine transport (GO:0015822)?
Ornithine transport is the directed movement of ornithine, 2,5-diaminopentanoic acid, into, out of, or within a cell, or between cells, by means of a transporter or pore.
What genes are involved in ornithine transport?
Key genes include SLC25A15 (mitochondrial ornithine/citrulline carrier), SLC7A1 (CAT1 plasma membrane transporter), and SLC45A4 (peroxisomal putrescine transporter) [3,4,7,8].
How is ornithine transported into mitochondria?
The mitochondrial ornithine/citrulline carrier (ORC/SLC25A15) exchanges ornithine for citrulline and can also catalyze ornithine+/H+ exchange [3,5].
What diseases are linked to ornithine transport defects?
HHH syndrome, retinal cytotoxicity, cystinuria, and autoimmune conditions have been linked to ornithine transport dysfunction [1,2,3,4,7].
What is the role of CAT1 in ornithine transport?
CAT1 (SLC7A1) mediates L-ornithine uptake across the plasma membrane, including at the blood-retinal barrier, and is involved in ornithine cytotoxicity in retinal pigment epithelial cells [4,7].
How can I study ornithine transport using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the function of transporters like SLC25A15, SLC7A1, and SLC45A4 [1,3,4,7,8].
What is the peroxisomal putrescine transporter SLC45A4?
SLC45A4 encodes a peroxisomal putrescine transporter that promotes GABA de novo synthesis, linking ornithine metabolism to peroxisomal function.
Is ornithine transport involved in autoimmunity?
Single-cell metabolic modeling of Th17 cells identified ornithine transport as a regulator of autoimmunity, suggesting a role in T cell function.
What methods are used to measure ornithine transport?
Radiolabeled uptake assays, reconstituted proteoliposomes, metabolic modeling, and CRISPR screens are commonly used [1,4,5,6].
Why is ornithine transport important for the urea cycle?
Ornithine transport into mitochondria is required for the urea cycle, as ornithine is a substrate for ornithine transcarbamylase and is exchanged for citrulline [3,5].
Conclusion
Ornithine transport (GO:0015822) is a fundamental biological process that governs the movement of ornithine across cellular membranes, supporting urea cycle function, polyamine synthesis, and peroxisomal metabolism [3,5,8]. Dysregulation of this transport is linked to severe disorders including HHH syndrome, retinal cytotoxicity, and cystinuria, and emerging evidence implicates it in autoimmunity [1,2,3,4,7]. By leveraging CRISPR-based models and advanced metabolic profiling, researchers can dissect the molecular mechanisms of ornithine transport and develop targeted therapies. EDITGENE offers comprehensive services to accelerate these discoveries.
References
- 1. Wagner A et al.. 2021. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity.. Cell 184(16):4168-4185.e21 PMID: 34216539
- 2. Crawhall JC et al.. 1968. Cystinuria.. Am J Med 45(5):736-55 PMID: 4879834
- 3. Palmieri F et al.. 1996. Mitochondrial metabolite transporters.. Biochim Biophys Acta 1275(1-2):127-32 PMID: 8688445
- 4. Kubo Y et al.. 2015. Impact of Cationic Amino Acid Transporter 1 on Blood-Retinal Barrier Transport of L-Ornithine.. Invest Ophthalmol Vis Sci 56(10):5925-32 PMID: 26377079
- 5. Indiveri C et al.. 1999. The purified and reconstituted ornithine/citrulline carrier from rat liver mitochondria catalyses a second transport mode: ornithine+/H+ exchange.. Biochem J 341 ( Pt 3)(Pt 3):705-11 PMID: 10417335
- 6. Thompson J. 1987. Ornithine transport and exchange in Streptococcus lactis.. J Bacteriol 169(9):4147-53 PMID: 3114235
- 7. Kaneko S et al.. 2007. Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells.. Invest Ophthalmol Vis Sci 48(1):464-71 PMID: 17197568
- 8. Colson C et al.. 2025. SLC45A4 encodes a peroxisomal putrescine transporter that promotes GABA de novo synthesis.. Nat Commun 16(1):10198 PMID: 41266324
